Literature DB >> 26555810

ADHD and behavioral disorders: Assessment, management, and an update from DSM-5.

Joseph Austerman1.   

Abstract

Behavioral disorders in pediatric patients--primarily attention deficit hyperactivity disorder (ADHD)--pose a clinical challenge for health care providers to accurately assess, diagnose, and treat. In 2013, updated diagnostic criteria for behavioral disorders were published, including ADHD and a new diagnostic entity: disruptive mood dysregulation disorder. Revised criteria for ADHD includes oldest age for occurrence of symptoms, need for symptoms to be present in more than one setting, and requirement for number of symptoms in those aged 17 and older. Assessment of ADHD relies primarily on the clinical interview, including the medical and social history, along with the aid of objective measures. The clinical course of ADHD is chronic with symptom onset occurring well before adolescence. Most patients have symptoms that continue into adolescence, and some into adulthood. Many patients with ADHD have comorbid disorders such as depression, disruptive behavior disorders, or substance abuse, which need to be addressed first in the treatment plan. Treatment of ADHD relies on a combination of psychopharmacologic, academic, and behavioral interventions, which produce response rates up to 80%.
Copyright © 2015 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26555810     DOI: 10.3949/ccjm.82.s1.01

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  15 in total

Review 1.  Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Authors:  Sarah C O S Padilha; Suzane Virtuoso; Fernanda S Tonin; Helena H L Borba; Roberto Pontarolo
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-19       Impact factor: 4.785

2.  Tic Disorders, Anti-Tic Medications, and Risk of Atopy.

Authors:  Mathew Hakimi; Sandra Skinner; Carine W Maurer
Journal:  Mov Disord Clin Pract       Date:  2022-07-12

3.  Children with attention-deficit/hyperactivity disorder spend more time in hyperconnected network states and less time in segregated network states as revealed by dynamic connectivity analysis.

Authors:  Heather M Shappell; Kelly A Duffy; Keri S Rosch; James J Pekar; Stewart H Mostofsky; Martin A Lindquist; Jessica R Cohen
Journal:  Neuroimage       Date:  2021-01-14       Impact factor: 6.556

4.  Outpatient rehabilitation resources and medical expenditure in children with attention-deficit hyperactivity disorder in Taiwan.

Authors:  Hsing-Jung Li; Chao-Chan Kuo; Yi-Chien Yao; Ching-Hong Tsai; Philip C Chow; Ying-Chun Li
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

Review 5.  Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder.

Authors:  Amber N Edinoff; Haseeb A Akuly; John H Wagner; Megan A Boudreaux; Leah A Kaplan; Shadman Yusuf; Elisa E Neuchat; Elyse M Cornett; Andrea G Boyer; Adam M Kaye; Alan D Kaye
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

Review 6.  Developmental exposure to methylmercury and ADHD, a literature review of epigenetic studies.

Authors:  Tao Ke; Alexey A Tinkov; Antoly V Skalny; Aaron B Bowman; Joao B T Rocha; Abel Santamaria; Michael Aschner
Journal:  Environ Epigenet       Date:  2021-11-22

7.  Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment.

Authors:  M Janelle Cambron-Mellott; Jaromir Mikl; Joana E Matos; Jennifer G Erensen; Kathleen Beusterien; Marc J Cataldo; Bernadette Hallissey; Gregory W Mattingly
Journal:  Patient Prefer Adherence       Date:  2021-05-21       Impact factor: 2.711

8.  Adolescent depressed mood and difficulties with emotion regulation: Concurrent trajectories of change.

Authors:  Annamarie B Defayette; Emma D Whitmyre; Roberto López; Bradley Brown; Jennifer C Wolff; Anthony Spirito; Christianne Esposito-Smythers
Journal:  J Adolesc       Date:  2021-07-09

9.  A Predictive Model Offor Attention Deficit Hyperactivity Disorder Based on Clinical Assessment Tools.

Authors:  Dai Han; Yantong Fang; Hong Luo
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-25       Impact factor: 2.570

Review 10.  The Association between ADHD and Environmental Chemicals-A Scoping Review.

Authors:  Sonja Moore; Laura Paalanen; Lisa Melymuk; Andromachi Katsonouri; Marike Kolossa-Gehring; Hanna Tolonen
Journal:  Int J Environ Res Public Health       Date:  2022-03-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.